Medications
Semaglutide, Tirzepatide
Monthly Cost
$199 – $399
Speed to Start
Slow: 2 to 3 Weeks
Trustpilot
Not yet rated
Compounded Medications
Est. 2026
About Synergy RX
Synergy RX is among the newest entrants in the compounded GLP-1 market, founded in 2026. The platform offers compounded semaglutide and tirzepatide via subcutaneous injection, with monthly pricing ranging from $199 to $399.
As a brand-new platform, Synergy RX has no Trustpilot reviews, no BBB listing, and no publicly verifiable track record. This isn’t unusual for a just-launched telehealth company, but it means patients have zero independent data to evaluate the actual patient experience. Trust and compliance transparency is rated low.
The clinical program is minimal — no lab testing, no dietitian access, and low ongoing support. Onboarding is notably slow at 2 to 3 weeks, which is below average for the telehealth GLP-1 market where many competitors offer same-day or next-day prescriptions. Cost transparency is rated medium.
The compounded-only model with unknown CoA testing status and undisclosed pharmacy partners adds sourcing concerns. For a platform with no external validation to offset these gaps, the risk profile is elevated compared to established competitors at similar price points.
Patients considering Synergy RX should weigh the complete absence of reputation data against the availability of more established alternatives that have been independently reviewed and rated by patients.
Synergy RX GLP-1 Medications
At a Glance
Medications Offered
Semaglutide, Tirzepatide
Compounded
Cost & Insurance
- Monthly: $199 – $399
- 6-month estimate: $1200 – $2400
- Insurance: No
- Self-pay: Yes
Clinical Features
- Lab testing: No
- Dietitian access: No
- BBB Rating: –
Delivery & Access
- Format: Subcutaneous
- Nationwide telehealth: Yes
- Speed: Slow: 2 to 3 Weeks
- Spanish-speaking providers: Not available
What the Synergy Rx Intake Looks Like
We walked through Synergy Rx’s full GLP-1 intake ourselves, from the BMI calculator through two condition multi-selects to the approve-first-charge checkout. Here’s what an actual prospective patient encounters before being prescribed — including a notable FDA-black-box gap and a contradictory consultation-fee disclosure.
/ 10
Notably weaker than peer compounded providers. Synergy Rx asks two condition multi-selects with a suicidal-thoughts checkbox and the cancer 5-year-remission threshold, but MTC and MEN2 family history are not asked anywhere in the visible flow — a significant FDA-black-box gap. There is also no allergy screen, no eating-disorder check, no medication list, and no BP/HR reading.
/ 10
Low. Anonymous-friendly questionnaire — name, email, and phone aren’t collected until after every clinical question. Approve-first-charge applies at the plan-selection step, but the consultation-fee disclosure contradicts itself ($80 on one screen, $59 on another) and the brand identity is muddled (RxActivate appears at checkout instead of Synergy Rx).
The 5 Stages
Clinical Safety Screens Performed
Medullary Thyroid Cancer (MTC) and Multiple Endocrine Neoplasia type 2 (MEN2) family history are the GLP-1 class FDA black-box warning, and most compounded providers in our catalog ask about them as a dedicated checkbox or a multi-select item. Synergy Rx does not ask about MTC or MEN2 anywhere in the visible 16-screen flow — neither personal history nor family history. The intake also doesn’t include pancreatitis, gastroparesis, anorexia or bulimia, an opiate or alcohol screen, an allergy screen of any kind, or a medication list (current meds is a Yes/No only). Sex is collected as a binary Male / Female only, and no actual blood pressure or heart-rate reading is captured.
The TeleHealth-visit fee surfaces in two contradictory amounts. The billing-cycle screen states: “There is an $80 TeleHealth visit cost regardless of whether I receive medication.” The Care Validate disclosure on the final payment page reads: “You will be charged $59 for your initial TeleHealth visit.” Patients should not assume either amount is the binding figure — both quotes are visible in the same flow.
The Care Validate copy on the final screen also references “RxActivate remains your primary service provider” rather than “Synergy Rx,” suggesting RxActivate is the underlying entity operating multiple consumer brands on the same Care Validate billing infrastructure. Patients may see CAREVALIDATE or RxActivate on card statements rather than Synergy Rx.
Source: GLP-1.Reviews editorial walkthrough on April 30, 2026. We completed every screen of the Synergy Rx weight-loss intake using a representative GLP-1 candidate persona and stopped before submitting any payment information.
Opens synergyrx.co in a new tab.
Start your GLP-1 weight loss journey with Synergy RX today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.
